Israel’s Teva has launched generic versions of the anti-nausea treatment ALOXI and Lialda delayed-release mesalamine. It is good news for cancer patients receiving chemotherapy and ulcerative colitis sufferers respectively.
https://www.tevagenerics.com/product/palonosetron-hydrochloride-injection
https://www.tevagenerics.com/product/mesalamine-delayed-release-tablets-usp